4DMedical is trading 5.01% up now at A$3.98, primarily reflecting broader healthcare-sector strength.
- No fresh August 20, 2026 company-specific announcement was identified.
- The latest notable development was an August 17 strategic OEM and reseller partnership with Azra AI, integrating coordinated-care tools with 4DMedical’s lung-imaging technology.
- Healthcare is up 3.23%, supported by earnings optimism, regulatory momentum, M&A activity and investor rotation.